Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers
<h4>Background</h4> <p>Antiphospholipid antibodies (aPL) can be detected in asymptomatic carriers and infectious patients. The aim was to investigate whether a novel line immunoassay (LIA) differentiates between antiphospholipid syndrome (APS) and asymptomatic aPL+ carriers or pat...
Egile Nagusiak: | Roggenbuck, D, Borghi, M, Somma, V, Büttner, T, Schierack, P, Hanack, K, Grossi, C, Bodio, C, Macor, P, Von Landenberg, P, Boccellato, F, Mahler, M, Meroni, P |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
BioMed Central
2016
|
Antzeko izenburuak
-
Antiphospholipid antibodies in Brazilian hepatitis C virus carriers
nork: A.M. Atta, et al.
Argitaratua: (2008-06-01) -
Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
nork: Francesco Tedesco, et al.
Argitaratua: (2018-06-01) -
New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats
nork: Paolo Durigutto, et al.
Argitaratua: (2019-04-01) -
Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers
nork: Ilenia Calcaterra, et al.
Argitaratua: (2021-01-01) -
Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome
nork: Leiyi Yang, et al.
Argitaratua: (2025-03-01)